EOLS - CIK 0001570562
The table below shows Evolus, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$42.27M | -$18.00M | -$34.01M | -$84.91M | -$33.39M | -$57.87M |
| Capital expenditure | $3.44M | $1.47M | $473.00K | $1.62M | $393.00K | $815.00K |
| Investing cash flow | -$8.45M | -$4.82M | -$1.63M | -$2.94M | $4.03M | $12.19M |
| Dividends paid | - | - | - | - | - |
Evolus, Inc. reported operating cash flow of -$42.27M for fiscal year 2025. That is down 134.8% from -$18.00M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$13.22M (FY 2017) to -$42.27M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $17.34M | $47.41M | $44.64M | -$4.15M | $73.05M | $38.35M |